2014
DOI: 10.1128/aac.01531-13
|View full text |Cite
|
Sign up to set email alerts
|

Susceptibility Profiles of Nocardia Isolates Based on Current Taxonomy

Abstract: The genus Nocardia has undergone rapid taxonomic expansion in recent years, and an increasing number of species are recognized as human pathogens. Many established species have predictable antimicrobial susceptibility profiles, but sufficient information is often not available for recently described organisms. Additionally, the effectiveness of sulfonamides as first-line drugs for Nocardia has recently been questioned. This led us to review antimicrobial susceptibility patterns for a large number of molecularl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

18
116
5
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 143 publications
(149 citation statements)
references
References 18 publications
18
116
5
1
Order By: Relevance
“…Isolates that phenotypically resemble N. asteroides are usually divided into six different drug susceptibility patterns (5). However, while correct identification to species level allows the prediction of likely antimicrobial susceptibility patterns, infrequently reported species may pose a challenge, prompting susceptibility testing of all isolates (5,11,12). Our isolate proved susceptible to the majority of antimicrobials tested for Nocardia species, with the exception of ciprofloxacin, contrasting with other reported N. thailandica isolates (7), which exhibited completely different patterns, thus suggesting important interspecies variability and/or methodological differences.…”
contrasting
confidence: 47%
“…Isolates that phenotypically resemble N. asteroides are usually divided into six different drug susceptibility patterns (5). However, while correct identification to species level allows the prediction of likely antimicrobial susceptibility patterns, infrequently reported species may pose a challenge, prompting susceptibility testing of all isolates (5,11,12). Our isolate proved susceptible to the majority of antimicrobials tested for Nocardia species, with the exception of ciprofloxacin, contrasting with other reported N. thailandica isolates (7), which exhibited completely different patterns, thus suggesting important interspecies variability and/or methodological differences.…”
contrasting
confidence: 47%
“…Identification of this species in clinical settings is important as it is reported to possess some degree of resistance to cotrimoxazole and minocycline (Minero et al, 2009). Intraspecies variation in susceptibility to imipenem has also been reported in N. cyriacigeorgica (Schlaberg et al, 2014). Recently, genomic sequencing of N. cyriacigeorgica (GUH-2 strain) revealed virulence determinants such as the production of superoxide dismutase and peptide synthesis probably for siderophore/toxin production (Zoropogui et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Nocardia species exhibit a species-predictable antimicrobial susceptibility pattern, and early species identification may be a crucial step to start an adapted antibiotherapy (11). When bacterial cultures were positive, the isolates were correctly identified by MALDI-TOF at the genus level, and the lack of accurate identification at the species level is easily explained because N. cerradoensis was not included in the database.…”
mentioning
confidence: 98%
“…In our case, we decided to initiate treatment with wide-spectrum antibiotics that also cross the blood-brain barrier. Actually, Nocardia shows a lower percentage of resistance to linezolid, SXT, and amikacin (11,15). Carbapenem usually displays a low MIC, and meropenem exhibits the best cerebral diffusion among this class.…”
mentioning
confidence: 99%